Company Filing History:
Years Active: 2007
Title: **Hetian Lei: Innovator in Cancer Research**
Introduction
Hetian Lei is an accomplished inventor based in Beijing, China. With a focus on innovative solutions in the medical field, particularly in cancer treatment, he has made significant strides through his patented work.
Latest Patents
Hetian Lei holds a patent for "Antagonist peptides to VEGF receptor Flt-1." This invention offers a polypeptide or a pharmacologically acceptable salt comprising one or more amino acid sequences that are crucial in treating angiogenic diseases such as solid tumors. Additionally, it includes a polynucleotide that encodes this polypeptide, emphasizing its potential application in gene therapy.
Career Highlights
Currently, Hetian Lei works at the Beijing Institute for Cancer Research, where his expertise plays a vital role in advancing cancer therapies. His innovative research contributes significantly to understanding and combating cancer progression.
Collaborations
Throughout his career, Hetian has collaborated with esteemed colleagues, including Chengchao Shou and Ping An. Together, they work towards creating pioneering solutions in cancer addiction therapy, enhancing the collaborative efforts within their research institution.
Conclusion
As an inventor, Hetian Lei exemplifies the spirit of innovation within the field of cancer research. His contributions through patents not only demonstrate his expertise but also offer hope for future advancements in cancer treatment. Through his work, he continues to inspire fellow researchers and inventors in the pursuit of medical breakthroughs.